Cas No.: 1193347-53-3
PRODUCT INFORMATION
Description
Cyclo(Arg-Ala-Asp-D-Tyr-Lys) (c(RADyK)) serves as a critical negative control peptide for c(RGDyK) studies. The substitution of Gly with Ala at position 2 (RGD→RAD) disrupts the native αVβ3 integrin binding capability. This structural modification enables researchers to differentiate RGD-mediated biological effects from nonspecific interactions in integrin-targeted in vitro experiments.
Molecular Weight
633.70
Purity
> 95%
Formula
C₂₈H₄₃N₉O₈
Product Type
Targeting Peptide
Sequence
Cyclo[Ala-D-Asp-D-Tyr-Lys-Arg]
Form (20 deg.C)
Solid
Storage Condition
Store the product under the recommended conditions in the Certificate of Analysis (CoA).
For Research Use Only | Not For Clinical Use
Related products
- C16Y Targeting Peptide (CAT#: OLY-1025-YS-7)
- Tyr-Somatostatin-14 Targeting Peptide (CAT#: OLY-1025-YS-63)
- Cyclo(-RGDfK) TFA Targeting Peptide (CAT#: OLY-1025-YS-53)
- CGGK Targeting Peptide (CAT#: OLY-1025-YS-27)
- Thrombospondin-1 (1016-1021) (human, Bovine, Mouse) Targeting Peptide (CAT#: OLY-1025-YS-45)
- rTAT Targeting Peptide (CAT#: OLY-1025-YS-20)
- Octreotide Pamoate Targeting Peptide (CAT#: OLY-1025-YS-4)
- Thrombin-cleavable Targeting Peptide (CAT#: OLY-1025-YS-34)
Online Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.